Greenwalt TJ. An autobiographical perspective of blood banking, 1946 to 1988. Transfusion 1989;29:248–58.Search in Google Scholar
Mourant AE. The establishment of an international panel of blood donors of rare types. Vox Sang 1965;10:129–32.Search in Google Scholar
Keller M, Kavitsky V, Maurer J, Nance S, Facey D. The American Rare Donor Program: 25 years of providing rare blood to alloimmunized patients. Transfusion 2023;63(Suppl):58A–9A.Search in Google Scholar
Rare blood types some day may save your life: Dr Phil Sturgeon builds “rare blood.” Palisadian Post. 4 January 1962.Search in Google Scholar
Special lab facilities aid in search for more rare-blood type donors. Lab World. November 1963.Search in Google Scholar
Peyrard T. The French national rare blood program. Immunohematology 2016;32:23–5.Search in Google Scholar
Moullec J. Donors of rare groups: elaboration of a central card index [in French]. Transfusion (Paris) 1965;8:365–9.Search in Google Scholar
Moullec J. The national index of rare type donors [in French]. Transfusion (Paris) 1966;9:163–6.Search in Google Scholar
Fialaire-Legendre A, Chami B, Peyrard T, et al. The organization of the National Blood Bank for Rare Blood Units in France. Blood 2008;112(Suppl):1045.Search in Google Scholar
Mallory D, Malamut D, Sandler SG. A decade of rare donor services in the United States. Vox Sang 1992;63:186–91.Search in Google Scholar
The American Rare Donor Program standard operating procedure, version 083023.Search in Google Scholar
Beattie K, Shafer W. Broadening the base of a rare donor program by targeting minority populations. Transfusion 1986;26:401–4.Search in Google Scholar
Flickinger C, Horn T, Meny GM, Nance S. Providing units for patients with anti-E and antibodies to hrB, hrS, or e variants. Transfusion 2014;54(Suppl):149A.Search in Google Scholar
Keller MA, Johnson N, Nance SJ. Meeting the needs of rare U negative units: survey of blood center practices. Transfusion 2017;57(Suppl 3):151A.Search in Google Scholar
Fludd D, Keller M, Facey D, Nance S. Characterizing requests for rare S– s–/Uneg/U+VAR units: review of seven years of request data from the American Rare Donor Program. Transfusion 2019;59:211A.Search in Google Scholar
Karp JK, Flickinger C, Nance S, Meny G. Donation, deferral, and telerecruitment patterns of high frequency antigen negative donors. Transfusion 2011;51(Suppl):106A.Search in Google Scholar
Karp JK, Flickinger C, Nance S, Meny G. Demographics of high frequency antigen negative rare donors. Transfusion 2011;51(Suppl):109A–10A.Search in Google Scholar
Maurer JL, Nance S. American Rare Donor Program (ARDP): provision of units for high prevalence antigen requests. Transfusion 2017;57(Suppl 3):209A.Search in Google Scholar
Facey DA, Nance S, Maurer JL, Fludd D, Keller MA. American Rare Donor Program (ARDP) requests for red blood cell units lacking high prevalence antigens. Transfusion 2019;59:141A.Search in Google Scholar
Maurer JL, Nance S, Kavitsky V, Facey D, Keller MA. High prevalence antigen negative unit requests: what if it includes being O negative? Transfusion 2021;61(Suppl 3):159A–60A.Search in Google Scholar
Kavitsky V, Maurer JL, Facey D, Keller M, Nance S. Phenorare requests to the American Rare Donor Program (ARDP): how soon will you get the rare blood? Transfusion 2020;60: 244A–5A.Search in Google Scholar
Keller MA. RH genetic variation and the impact for typing and personalized transfusion strategies: a narrative review. Ann Blood 2022;8:18.Search in Google Scholar
Karp JK, Flickinger C, Nance S, Meny G. Demographics and donation patterns of IgA deficient rare donors. Transfusion 2011;51(Suppl):100A.Search in Google Scholar
International Blood Group Reference Laboratory. International rare donor panel. Available from https://www.nhsbt.nhs.uk/ibgrl/services/international-rare-donor-panel/. Accessed 9 July 2024.Search in Google Scholar
Kavitsky V, Maurer J, Facey D, Keller M, Nance S. American Rare Donor Program (ARDP): data from requests meeting Alert categories. Transfusion 2020;60:225A.Search in Google Scholar
Facey D, Kavitsky V, Keller M, Maurer J, Nance S. American Rare Donor Program (ARDP): should patients with exquisitely rare phenotypes have units frozen for future use? Transfusion 2021;61(Suppl 3):199A.Search in Google Scholar
AABB standards for immunohematology reference laboratories. 13th ed. Bethesda: A ABB, 2024. Available from https://www.aabb.org/aabb-store/product/standards-forimmunohematology-reference-laboratories-13th-edition-print-17356740. Accessed 17 September 2024.Search in Google Scholar
Sesok-Pizzini DA, Friedman DF, Smith-Whitley K, Nance SJ. Transfusion support of patients with sickle cell disease at the Children’s Hospital of Philadelphia. Immunohematology 2006;22:121–5.Search in Google Scholar
Chou ST, Jackson T, Vege S, Smith-Whitley K, Friedman DF, Westhoff CM. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood 2013;122:1062–71.Search in Google Scholar
Chou ST, Alsawas M, Fasano RM et al. American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support. Blood Adv 2020;4:327–55.Search in Google Scholar
Fludd D, Ekema E, Maurer J, Facey D, Keller M, Nance S. Checking prior antibody history associated with rare blood requests. Transfusion 2018;58:213A.Search in Google Scholar
Fludd D, Maurer J, Facey D, Keller M, Nance S. Implementation of routine prior history checks for requests for rare units made to American Rare Donor Program. Transfusion 2019;59:216A.Search in Google Scholar
Schwickerath V, Kowalski M, Menitove JE. Regional registry of patient alloantibodies: first-year experience. Transfusion 2010;50:1465–70.Search in Google Scholar
Jones DS Jr, Folk G, Wilson J, et al. A regional red cell antibody registry improves patient safety but is underutilized. Transfusion 2023;63:1778–81.Search in Google Scholar
Mathur G, Wilkinson MB, Island ER, Menitove JE, Tilzer L. A case for a national registry of red blood cell antibodies. Vox Sang 2022;117:738–40.Search in Google Scholar
U.S. Department of Health and Human Services. Toward the development of a national red blood cell antibody patient data exchange (RBCAX): 2023 interim report. Available from https://www.hhs.gov/sites/default/files/toward-development-national-red-blood-cell-antibody-patient-data-exchange.pdf. Accessed 21 January 2024.Search in Google Scholar
Nance S, Kavitsky V, Maurer J, Facey D, Keller M. Managing requests for rare blood in a pandemic: American Rare Donor Program data. 2021 Vox Sang;116(Suppl 1):44–5.Search in Google Scholar
Keller MA, Kavitsky V, Maurer J, Facey D. The American Rare Donor Program’s support of patients with sickle cell disease. Vox Sang 2023;118(Suppl 1):101–2.Search in Google Scholar
Keller MA, Horn T, Crowley J, Nance S, Meny G, Flickinger C. Genotype compatibility tables for matching patients and donors for Rh variants. Transfusion 2013;53(Suppl 1):174A.Search in Google Scholar
Keller MA, Crowley J, Horn T, et al. Characterization of the RH locus in African American blood donors. Transfusion 2013;53(Suppl 1):28A.Search in Google Scholar
Keller MA, Horn T, Maurer J, Nance S. RH genotype matching: the experience of the American Rare Donor Program. Vox Sang 2017;112(Suppl 1):70.Search in Google Scholar
Keller MA, Horn T, Fludd DR, Maurer JL, Nance SJ. RH allele matching for Rh alloimmunized patients: personalized medicine to the nth degree. Transfusion 2019;59(Suppl 3):143A.Search in Google Scholar
Friedman D, Chou S, Keller MA, Vege S, Jackson T, Westhoff C. Feasibility analysis for RH gene-based matching between an African American donor pool and a population of patients with sickle cell disease. Transfusion 2014;54(Suppl 2):30A.Search in Google Scholar
Flickinger C, Vege S, Meny GM, Nance SJ. Impact of molecular testing on fill rates in the American Rare Donor Program. Transfusion 2010;50(Suppl):174A.Search in Google Scholar
Keller MA, Kavitsky V, Maurer J, Facey D, Nance S. RHCE*ce733G, alloimmunization and meeting the blood needs of alloimmunized patients. Transfusion 2021;61(Suppl 3): 145A–6A.Search in Google Scholar
Kavitsky V, Maurer J, Facey D, Keller M. Meeting the blood needs of alloimmunized patients lacking RH19. Vox Sang 2022;117(Suppl 1):210.Search in Google Scholar
Keller MA, Mansfield P, Maurer J, Ligthart P, Danovic F, Nance S. Identifying compatible blood for Rh alloimmunized patients: an international case. Vox Sang 2019;114(Suppl 1):85.Search in Google Scholar
Turner TR, Acker JP. A Canadian perspective on the use and preparation of cryopreserved red cell concentrates. Transfus Apher Sci 2020;59:102853. doi: 10.1016/j.transci.2020.102853.Search in Google Scholar
Peyrard T, Pham BN, Le Pennec PY, Rouger P. Transfusion of rare cryopreserved red blood cell units stored at –80 degrees C: the French experience. Immunohematology 2009;25:13–7.Search in Google Scholar
Keller MA, Kavitsky V, Maurer J, ARDP member facilities. Managing a frozen rare blood inventor y: a survey of American Rare Donor Program member facilities. Vox Sang 2024;119(Suppl 1):438–9.Search in Google Scholar
Munks R, Booth JR, Sokol RJ. A comprehensive IgA service provided by a blood transfusion center. Immunohematology 1998;14:155–60.Search in Google Scholar
Tacquard C, Boudjedir K, Carlier M, Muleer J-Y, Gomis P, Mertes PM. Hypersensitivity transfusion reactions due to IgA deficiency are rare according to French hemovigilance data. J Allergy Clin Immunol 2017;140:884–5.Search in Google Scholar
Sandler SG, Eder A, Goldman M, Winters JL. The entity of immunoglobulin A–related anaphylactic transfusion reactions is not evidence based. Transfusion 2015;55:199–204.Search in Google Scholar
Keller MA, Kavitsky V, Maurer J, et al. IgA-deficient donors: screening process and data from three US centers. Transfusion 2023;63(Suppl 5):119A.Search in Google Scholar
Keller MA, Powley T, Sareneva I, et al. Rare donor programs and IgA deficiency defining the landscape. Vox Sang 2024;119(Suppl 1):436.Search in Google Scholar
Keller MA, Kavitsky V, Maurer J, Facey DA, Babariya SP. Determining the validity of IgA deficient product requests submitted to the American Rare Donor Program from 2018 to 2022. Transfusion 2023;63(Suppl 5):110A.Search in Google Scholar
Manigly M, Fludd D, Nance S. Rare donor engagement with American Rare Donor Program (ARDP). Transfusion 2017;57(Suppl 3):225A.Search in Google Scholar
Maurer J, Kavitsky V, Facey D, Keller M, Nance S. The American Rare Donor Program (ARDP) and rare donor recruitment: results of recruitment requests in December 2019. Transfusion 2020;60:69A.Search in Google Scholar
Nance S. How to find, recruit and maintain rare blood donors. Curr Opin Hematol 2009;16:503–8.Search in Google Scholar
Kavitsky V, Maurer J, Facey D, Keller M, Nance S. American Rare Donor Program (ARDP): an analysis of donor retention. Transfusion 2021;61(Suppl 3):31A.Search in Google Scholar
Nance S, VanThof L, Kaherl K, et al. Survey of the American Rare Donor Program: new insights into enumerating rare donors and rare blood requests in the USA. Transfusion 2021;61(Suppl 3):17A.Search in Google Scholar
Nance S. The monocyte monolayer assay, an in vitro method for prediction of in vivo survival of transfused incompatible red blood cells: a review. Immunohematology 2023;39:61–9.Search in Google Scholar
Maurer JL, Facey DA, Keller MA, Fludd DR, Nance SJ. Analysis of American Rare Donor Program (ARDP) unfilled rare unit requests. Transfusion 2019;59(Suppl 3):164A.Search in Google Scholar
Khan F, Singh K, Friedman MT. Artificial blood: the history and current perspectives of blood substitutes. Discoveries 2000;8:e104.Search in Google Scholar
Jahr JS. Blood substitutes: basic science, translational studies and clinical trials. Front Med Technol 2022;4:989829. doi: 10.3389/fmedt.2022.989829.Search in Google Scholar
International Society of Blood Transfusion. Rare donors. Available from https://www.isbtweb.org/isbt-working-parties/rare-donors.html. Accessed 17 September 2024.Search in Google Scholar
Maurer J, Kavitsky V, Facey D, Keller M. The American Rare Donor Program and exports of rare blood products, 2008–2022. Transfusion 2023;63(Suppl 5):142A.Search in Google Scholar
Maurer J, Nance S, Kavitsky V Facey D, Keller M. When rare blood goes overseas. Transfusion 2021;61(Suppl 3):80A.Search in Google Scholar
Dodd R. Emerging pathogens and their implications for the blood supply and transfusion-transmitted infections. Br J Haematol 2012;159:135–42.Search in Google Scholar
Benitez N, Nance S, Bright F, et al. Domestic and international collaboration for the screening and procurement of rare red blood cells. Vox Sang 2019;114(Suppl 1):137.Search in Google Scholar
Gammon R, Tyler L, Alvarez H, et al. An international effort and use of social media to save a young girl. Vox Sang 2021;116:713–7.Search in Google Scholar
Sareneva I, Maurer J, Nikulainen H, Tossavainen J, Toivonen S, Korhonen A. Finnish Jk(a–b–) donors supporting oncologic treatment of a US patient. Vox Sang 2021;117(Suppl 1):43.Search in Google Scholar
Chou ST, Nance ST, Mansfield P, Friedman DF, Keller MA. Meeting the transfusion needs of a patient with anti-Ena requires an international effor t. Immunohematology 2024;40:10–4.Search in Google Scholar
Patch GC, Maurer J, Sendilnathan A, et al. How anti-c in a D– patient prompted a lifesaving work between a transfusion service and a blood center reference laboratory. Immunohematology 2024;40:73–7.Search in Google Scholar
Donatingblood.org. American rare donor program. Available from https://donatingblood.org/american-rare-donor-program/. Accessed 17 September 2024.Search in Google Scholar
Flickinger C. REGGI and the American Rare Donor Program. Transfus Med Hemother 2014;41:342–5.Search in Google Scholar
Keller MA. The role of red cell genotyping in transfusion medicine. Immunohematology 2015;31:49–52.Search in Google Scholar
Flickinger C, Meny GM, Nance SJ. The role of molecular genotyping in the submission of rare donors to the American Rare Donor Program (A RDP). Transfusion 2012;52(Suppl):155A.Search in Google Scholar
Vege S, Flickinger C, Nance S, Westhoff CM. Molecular characterization of hrB– donors from the American Rare Donor Program. Transfusion 2005;45(Suppl):131A.Search in Google Scholar
Thomas N, Alther R, Nance SJ, Vege S, Westhoff CM. High-throughput DNA molecular testing of African American donors: an efficient and productive method to prov ide phenotyped red cells. Transfusion 2010;50(Suppl):176A.Search in Google Scholar
Nance ST, Keller MA. Comments on: molecular matching of red blood cells is superior to serological matching in sickle cell disease patients. Rev Bras Hematol Hemoter 2013;35:3–17.Search in Google Scholar
Chou ST, Evans P, Vege S, et al. RH genotype matching for transfusion support in sickle cell disease. Blood 2018;132: 1198–207.Search in Google Scholar
Gleadall NS, Veldhuisen B, Gollub J, et al. Development and validation of a universal blood donor genotyping platform: a multinational prospective study. Blood Adv 2020:4:3495–506.Search in Google Scholar
Kim TY, Yu H, Phan MT, Jang JH, Cho D. Application of blood group genotyping by next-generation sequencing in various immunohaematology cases. Transfus Med Hemother 2021;49:88–96.Search in Google Scholar
Montemayor C, Brunker PAR, Keller MA. Banking with precision: transfusion medicine as a potential universal application in clinical genomics. Curr Opin Hematol 2019; 26:480–7.Search in Google Scholar
Wheeler MM, Johnsen JM. The role of genomics in transfusion medicine. Curr Opin Hematol 2018;25:509–15.Search in Google Scholar
McBean RS, Hyland CA, Flower RL . Approaches to determination of a full profile of blood group genotypes: single nucleotide variant mapping and massively parallel sequencing. Comput Struct Biotechnol J 2014;11:147–51.Search in Google Scholar
Liu Z, Liu M, Mercado T, Illoh O, Davey R. Extended blood group molecular typing and next-generation sequencing. Transfus Med Rev 2014;28:177–86.Search in Google Scholar
Keller MA. Challenges with assigning RH alleles and accurately predicting phenotypes using commercially available genotyping kits: a narrative review. Ann Blood 2024;9:4.Search in Google Scholar
Flickinger C. Miracles do happen: meeting the challenges of providing rare blood through the American Rare Donor Program. Immunohematology 2016;32:75–7.Search in Google Scholar
Nance S, Lomas-Francis C, ISBT Working Party on Rare Donors. Where in the world are rare donors? Vox Sang 2021;116(Suppl 1):9.Search in Google Scholar
Kim TY, Park M-S, Jang J-H, Woo H-Y, Cho D. Prevalence and molecular basis of null blood group phenotypes in the Korean population: analysis using a public database. Transfusion 2024;64:19–23.Search in Google Scholar
Moslemi C, Sækmose SG, Larsen R, et al. Genetic prediction of 33 blood group phenotypes using an existing genotype dataset. Transfusion 2023;63:2297–310.Search in Google Scholar
Kracalik I, Sapiano MRP, Wild RC, et al. Supplemental findings of the 2021 National Blood Collection and Utilization Survey. Transfusion 2023;63(Suppl 4):S19–42.Search in Google Scholar
